Total Payments
$9,501
2024 Payments
$2,789
Companies
30
Transactions
415
Medicare Patients
7,040
Medicare Billing
$583,144
Payment Breakdown by Category
Food & Beverage$9,022 (95.0%)
Education$478.92 (5.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,022 | 410 | 95.0% |
| Education | $478.92 | 5 | 5.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,136 | 92 | $0 (2024) |
| Janssen Biotech, Inc. | $921.47 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $833.19 | 35 | $0 (2024) |
| Amgen Inc. | $668.60 | 27 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $592.54 | 23 | $0 (2024) |
| UCB, Inc. | $577.09 | 24 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $516.49 | 25 | $0 (2024) |
| Lilly USA, LLC | $497.76 | 25 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $481.79 | 24 | $0 (2024) |
| GENZYME CORPORATION | $454.84 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,789 | 112 | ABBVIE INC. ($714.88) |
| 2023 | $2,405 | 96 | AbbVie Inc. ($499.16) |
| 2022 | $1,512 | 73 | ABBVIE INC. ($281.77) |
| 2021 | $893.57 | 47 | Janssen Biotech, Inc. ($153.08) |
| 2020 | $1,469 | 68 | AbbVie Inc. ($412.53) |
| 2019 | $431.71 | 19 | Janssen Biotech, Inc. ($117.86) |
All Payment Transactions
415 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Immunology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.07 | General |
| Category: Immunology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.03 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $34.88 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Inflammation | ||||||
| 11/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.84 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Dermatology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Immunology | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Immunology | ||||||
| 10/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.75 | General |
| Category: Immunology | ||||||
| 10/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,871 | 15,436 | $366,115 | $162,423 |
| 2022 | 19 | 1,784 | 14,151 | $347,048 | $153,496 |
| 2021 | 15 | 1,402 | 15,788 | $263,570 | $124,107 |
| 2020 | 19 | 1,983 | 9,682 | $347,718 | $143,118 |
Total Patients
7,040
Total Services
55,057
Medicare Billing
$583,144
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 314 | 436 | $85,347 | $39,317 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 256 | 301 | $41,538 | $19,306 | 46.5% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 35 | 12,400 | $31,000 | $15,797 | 51.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 282 | 353 | $35,477 | $13,826 | 39.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 170 | 193 | $30,687 | $13,143 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 118 | 118 | $29,884 | $12,438 | 41.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 128 | 152 | $26,372 | $11,558 | 43.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 92 | 92 | $15,594 | $6,984 | 44.8% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 37 | 65 | $19,175 | $6,491 | 33.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 214 | 1,057 | $10,570 | $5,435 | 51.4% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 38 | $10,346 | $4,158 | 40.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 27 | 32 | $8,080 | $3,957 | 49.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 53 | 75 | $6,056 | $3,016 | 49.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 23 | 24 | $4,770 | $2,164 | 45.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 32 | 34 | $2,890 | $1,416 | 49.0% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 11 | 11 | $2,233 | $1,061 | 47.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $2,489 | $1,006 | 40.4% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 15 | 15 | $2,051 | $692.64 | 33.8% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,433 | $645.53 | 45.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 16 | $124.00 | $12.09 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 294 | 400 | $78,300 | $36,724 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 223 | 266 | $36,708 | $16,910 | 46.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 206 | 237 | $37,683 | $16,416 | 43.6% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2022 | 27 | 11,200 | $28,000 | $13,833 | 49.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 117 | 117 | $29,630 | $12,672 | 42.8% |
About Dr. Rachel Byrd, M.D
Dr. Rachel Byrd, M.D is a Dermatology healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1235559741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rachel Byrd, M.D has received a total of $9,501 in payments from pharmaceutical and medical device companies, with $2,789 received in 2024. These payments were reported across 415 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($9,022).
As a Medicare-enrolled provider, Byrd has provided services to 7,040 Medicare beneficiaries, totaling 55,057 services with total Medicare billing of $583,144. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Chesapeake, VA
- Active Since 04/23/2014
- Last Updated 06/24/2024
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1235559741
Products in Payments
- DUPIXENT (Biological) $1,288
- RINVOQ (Biological) $885.06
- SKYRIZI (Biological) $834.54
- TREMFYA (Drug) $771.29
- Sotyktu (Drug) $592.54
- TALTZ (Drug) $409.22
- Otezla (Drug) $401.61
- COSENTYX (Drug) $324.15
- Cimzia (Drug) $319.29
- Enbrel (Biological) $266.99
- Bimzelx (Biological) $257.80
- HUMIRA (Biological) $252.37
- EUCRISA (Drug) $240.41
- ADBRY (Biological) $201.69
- ILUMYA (Biological) $179.68
- AMELUZ (Drug) $169.08
- Zoryve (Drug) $160.78
- COSENTYX (Biological) $131.34
- Winlevi (Drug) $125.01
- Tremfya (Drug) $117.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Chesapeake
William Dehart, Do, DO
Dermatology — Payments: $28,344
Dermatology $28,344
Dr. Bruce Bauer, Md, MD
Dermatology — Payments: $16,091
Dermatology $16,091
Indira Sookdeo, Pa-C, PA-C
Dermatology — Payments: $8,990
Dermatology $8,990
Dr. Stephan Duran, Md, Ms, MD, MS
Dermatology — Payments: $3,378
Dermatology $3,378
Jerome Parsons, Md, MD
Dermatology — Payments: $877.57
Dermatology $877.57
Dr. John Burgess, M.d, M.D
Dermatology — Payments: $225.75
Dermatology $225.75